Director/PDMR Shareholding - Replacement

RNS Number : 8850D
Georgia Capital PLC
01 July 2021
 

London, 1 July 2021

Director/PDMR Shareholding - Correction

 

The following announcement replaces the 'Director/PDMR Shareholding' announcement released on 30 June 2021 at 17:17 under RNS Number 7304D.

 

All of the grants should be described as in respect of discretionary deferred shares except for the last, which is in respect of salary shares.

 

The corrected announcement is set out in full below.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Irakli Gilauri

2.

Reason for the notification

a)

Position / status

PDMR, CEO and Chairman

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC

 

 

 

N/A

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

25% of the shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

160,000

 

 

 

d)

Aggregated information

 

 

Aggregated volume

 

Grant of 160,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

Aggregated price

n/a

 

 

 

e)

Dates of the transaction

29 June 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

         

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Avtandil Namicheishvili

2.

Reason for the notification

a)

Position / status

PDMR, Deputy CEO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC

 

 

 

 

N/A

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

25% of the shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

108,000

 

 

 

d)

Aggregated information

 

 

Aggregated volume

 

Grant of 108,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

Aggregated price

n/a

 

 

 

e)

Dates of the transaction

29 June 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

         

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Giorgi Alpaidze

2.

Reason for the notification

a)

Position / status

PDMR, CFO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC

 

 

 

N/A

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

33.3% of the shares will vest in each of the second, third and fourth years following the work year, subject to the terms of his service agreement.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

80,434

 

 

 

d)

Aggregated information

 

 

Aggregated volume

 

Grant of 80,434 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

Aggregated price

n/a

 

 

 

e)

Dates of the transaction

29 June 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

         

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nikoloz Gamkrelidze

2.

Reason for the notification

a)

Position / status

PDMR, CEO of Georgia Healthcare Group

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC

 

 

 

N/A

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

33.3% of the shares will vest in each of the second, third and  fourth years following the work year, subject to the terms of his service agreement.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

159,572

 

 

 

d)

Aggregated information

 

 

Aggregated volume

 

Grant of 159,572 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.

 

Aggregated price

n/a

 

 

 

e)

Dates of the transaction

29 June 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

         

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nikoloz Gamkrelidze

2.

Reason for the notification

a)

Position / status

PDMR, CEO of Georgia Healthcare Group

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification Code

Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC

 

 

 

 

N/A

 

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.

 

25% of the salary shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

35,000

 

 

 

d)

Aggregated information

 

 

Aggregated volume

 

Grant of 35,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.

 

Aggregated price

n/a

 

 

 

e)

Dates of the transaction

29 June 2021

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

 

 

 

 

 

 

 

Name of authorised official of issuer responsible for making notification:  

Link Company Matters, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAXFEFEFEFA
UK 100

Latest directors dealings